{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:28:51Z","timestamp":1787005731066,"version":"build-2736575974"},"reference-count":49,"publisher":"National Academy of Sciences","issue":"21","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":184,"URL":"https:\/\/www.pnas.org\/site\/aboutpnas\/licenses.xhtml"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["Sinergia grant 170929"],"award-info":[{"award-number":["Sinergia grant 170929"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["F32CA189372"],"award-info":[{"award-number":["F32CA189372"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007204","name":"Vallee Foundation","doi-asserted-by":"publisher","award":["Number"],"award-info":[{"award-number":["Number"]}],"id":[{"id":"10.13039\/100007204","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"crossref","award":["Forschungskredit 2017 ID 3761"],"award-info":[{"award-number":["Forschungskredit 2017 ID 3761"]}],"id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2021,5,25]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>A challenge in cancer therapy is delivering high, consistent levels of therapeutics to tumors. Protein-based therapeutics (e.g., antibodies) are typically delivered intravenously and require multiple doses to get sufficient levels to traffic into tumors to exert an effect. Yet healthy tissues are also exposed to similar drug levels, which can lead to significant side effects. This study uses sophisticated three-dimensional imaging of transparent tumors to characterize a versatile gene therapy platform using adenovirus that solves this problem by producing drugs directly in the tumor. This approach increases the tumor-to-bloodstream level of a model antibody 1,800-fold in comparison to direct administration. Thus, this system could allow for the local production of highly potent drugs with greatly reduced risk of systemic toxicities.<\/jats:p>","DOI":"10.1073\/pnas.2017925118","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:36:43Z","timestamp":1621269403000},"update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":30,"title":["The SHREAD gene therapy platform for paracrine delivery improves tumor localization and intratumoral effects of a clinical antibody"],"prefix":"10.1073","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2162-7107","authenticated-orcid":false,"given":"Sheena N.","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Biochemistry, University of Z\u00fcrich, 8057 Z\u00fcrich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajib","family":"Schubert","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Z\u00fcrich, 8057 Z\u00fcrich, Switzerland;"},{"name":"Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-3913","authenticated-orcid":false,"given":"Branko","family":"Simic","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Z\u00fcrich, 8057 Z\u00fcrich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3160-5542","authenticated-orcid":false,"given":"Dominik","family":"Br\u00fccher","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Z\u00fcrich, 8057 Z\u00fcrich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4533-371X","authenticated-orcid":false,"given":"Markus","family":"Schmid","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Z\u00fcrich, 8057 Z\u00fcrich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Kirk","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Z\u00fcrich, 8057 Z\u00fcrich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8803-6048","authenticated-orcid":false,"given":"Patrick C.","family":"Freitag","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Z\u00fcrich, 8057 Z\u00fcrich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Gradinaru","sequence":"additional","affiliation":[{"name":"Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4191-5306","authenticated-orcid":false,"given":"Andreas","family":"Pl\u00fcckthun","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Z\u00fcrich, 8057 Z\u00fcrich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2019.1703531"},{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2012.02.004"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1078\/1438-4221-00302"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0622"},{"key":"e_1_3_4_5_2","first-page":"33","article-title":"Monoclonal antibody therapy of solid tumors: Clinical limitations and novel strategies to enhance treatment efficacy","volume":"13","author":"Cruz E.","year":"2019","unstructured":"E. Cruz, V. Kayser, Monoclonal antibody therapy of solid tumors: Clinical limitations and novel strategies to enhance treatment efficacy. Biologics 13, 33\u201351 (2019).","journal-title":"Biologics"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3237"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/532162a"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-018-0006-z"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicines6030074"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.05.011"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-012017-043332"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri3191"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00868"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2010.10.040"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1213653110"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02707-6"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11672"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01518520"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043186"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/416279b"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2020.1792084"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0451-3"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1087"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-36-1-59"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1026"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biophys-070317-032905"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.122"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4593"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.07.017"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0b013e3182691c2a"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830111013"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32193"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2017.1337619"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.05.003"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158240"},{"key":"e_1_3_4_36_2","first-page":"5090","article-title":"Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: A role for altered tumor angiogenesis","volume":"61","author":"Viloria-Petit A.","year":"2001","unstructured":"A. Viloria-Petit ., Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: A role for altered tumor angiogenesis. Cancer Res. 61, 5090\u20135101 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_4_37_2","first-page":"1523","article-title":"Neutralizing antibodies against epidermal growth factor and ErbB-2\/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors","volume":"151","author":"Petit A. M.","year":"1997","unstructured":"A. M. Petit ., Neutralizing antibodies against epidermal growth factor and ErbB-2\/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors. Am. J. Pathol. 151, 1523\u20131530 (1997).","journal-title":"Am. J. Pathol."},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-1776"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169532"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2015.01.002"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4226"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2018.0019"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.612"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S172042"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4006"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.135"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.5.2509"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2013.09.001"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300142"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.2017925118","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.2017925118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T06:44:31Z","timestamp":1649832271000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.2017925118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":49,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2021,5,25]]}},"alternative-id":["10.1073\/pnas.2017925118"],"URL":"https:\/\/doi.org\/10.1073\/pnas.2017925118","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"2021-05-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2017925118"}}